Getty Images

Q and A with the experts: AstraZeneca and viral vector vaccines

Posted on

The AstraZeneca vaccine has recently been approved in Canada and is evaluated to be about 62 per cent effective in preventing the COVID-19 virus.

Kelly Grindrod, a pharmacist and professor, breaks down how this vaccine and others like it work.

https://uwaterloo.ca/news/media/q-and-experts-astrazeneca-and-viral-vector-vaccines

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]